Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Antisense Oligonucleotides
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Undisclosed
Sponsor : n-Lorem Foundation
Deal Size : Undisclosed
Deal Type : Partnership
Details : The partnership will supports and reduces the cost of manufacturing of n-Lorem’s experimental antisense oligonucleotide (ASO) medicines developed for nano-rare disease patients (1 to 30 patients worldwide) for free, for life.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
February 02, 2022
Lead Product(s) : Antisense Oligonucleotides
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Undisclosed
Sponsor : n-Lorem Foundation
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?